期刊
ONCOGENE
卷 36, 期 7, 页码 899-911出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/onc.2016.267
关键词
-
资金
- National Institute of Health (NIH) [CA104708, GM057549]
- American Heart Association (AHA) [10POST4290052, 13PRE14690057]
- Howard Hughes Medical Institute (HHMI) International Student Research Fellowship
Epithelial cells acquire migratory/invasive and stemness traits upon conversion to the mesenchymal phenotype. The expression of E-cadherin is a key to this transition; yet precise understanding of the pathways involved in integrating E-cadherin loss to the gain of mesenchymal traits remains poorly understood. Here, we show that phosphoinositide-generating enzyme, PIPKI gamma, expression is upregulated upon epithelial-mesenchymal transition (EMT) and together with the cytoskeletal protein talin assemble into a signaling complex upon E-cadherin loss. PIPKI gamma and talin together control the adhesion and phosphoinositide signaling that regulates conversion to the mesenchymal phenotypes. PIPKI gamma and talin regulate the stability of E-cadherin transcriptional repressors, snail and slug, induced by transforming growth factor-beta 1 or extracellular matrix protein. Loss of PIPKI gamma or talin or their interaction impaired EMT and the acquisition of cell motility and stemness. This demonstrates a mechanism where a phosphoinositide-generating enzyme PIPKI gamma couples with a cytoskeletal protein talin to control the acquisition of mesenchymal phenotypes.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据